SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 41.24 |
| Enterprise Value ($M) | 39.45 |
| Book Value ($M) | 0.75 |
| Book Value / Share | 0.02 |
| Price / Book | 55.27 |
| NCAV ($M) | -0.75 |
| NCAV / Share | -0.02 |
| Price / NCAV | -54.72 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -11.75 |
| Return on Assets (ROA) | -0.93 |
| Return on Equity (ROE) | -0.97 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.75 |
| Current Ratio | 0.75 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.24 |
| Assets | 3.74 |
| Liabilities | 2.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -7.31 |
| Net Income | -7.31 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -16.07 |
| Cash from Investing | 4.96 |
| Cash from Financing | 12.79 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,375 | 3,931 | 34.98 | |
| 988 | 7,778 | 12.70 | |
| 1,256 | 2,858 | 43.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EPIX – ESSA Pharma Inc. | EQ – Equillium, Inc. |
| ERNA – Eterna Therapeutics Inc. | EVOK – Evoke Pharma, Inc. |
| EYEN – Eyenovia, Inc. |
Financial data and stock pages provided by
Fintel.io